C. Ola Landgren, M.D.
Landgren joins CCR’s Medical Oncology Branch. He received his M.D. in 1995 from the Karolinska Institutet in Stockholm, Sweden. In 2004 he came to the NCI, Genetic Epidemiology Branch, DCEG, where he worked as a Principal Investigator. His research focuses on treatment-, host-, disease-, and immune-related factors in the pathway from precursor to full-blown hematologic malignancy and their relation to outcome.

Yinling Hu, Ph.D.
Hu joins CCR’s Laboratory of Experimental Immunology, Inflammation and Tumorigenesis Section. She received her undergraduate degree from the Chinese Academy of Medical Science and her Ph.D. from the University of Melbourne in Australia. Hu’s research interests are to understand the physiological activities of IKKα in skin tumorigenesis and inflammation and reveal the mechanisms of how IKKα regulates these functions by using genetic animal models.

Yamini Dalal, Ph.D.
Dalal joins CCR’s Laboratory of Receptor Biology and Gene Expression. She received her Ph.D. in 2003 from Purdue University for her work on nucleosome positioning in mammalian cells. She then went on to do postdoctoral research with Steven Henikoff, Ph.D., where she and colleagues discovered unusual properties associated with the centromere-specific chromatin in Drosophila. Her research program focuses on the interplay between chromatin ultra-structure and epigenetic regulation.

Joseph Ziegelbauer, Ph.D.
Ziegelbauer joins CCR’s HIV and AIDS Malignancy Branch. He received his Ph.D. from the University of California at Berkeley while in the laboratory of Robert Tjian, Ph.D. He later was a Damon Runyon Cancer Research Fellow with Don Ganem, M.D., at the University of California, San Francisco. He plans to utilize a new method he developed to study the functions of viral microRNAs in the context of cancer biology.

Jing Huang, Ph.D.
Huang joins CCR’s Laboratory of Cancer Biology and Genetics. He received his B.A. from Peking University and his Ph.D. from the University of Rochester. After finishing his postdoctoral training at the Wistar Institute, he joined the Laboratory of Cancer Biology and Genetics in 2008 to study cancer epigenetics.

Brian A. Lewis, Ph.D.
Lewis joins CCR’s Metabolism Branch. He received his Ph.D. in molecular biology from Princeton University, followed by postdoctoral fellowships at Harvard Medical School and the University of Medicine and Dentistry of New Jersey. He came to the NIH as a Visiting Scientist for two years before joining the Metabolism Branch as an Investigator in October 2008. The lab studies the eukaryotic transcriptional biochemistry of RNA polymerase II, the core promoters, and B-cell promoters.

Hyun Park, Ph.D.
Park joins CCR’s Experimental Immunology Branch. His research focuses on the role and mechanism of cytokine receptor regulation and signaling in immune cells. Park received his Ph.D. from the University of Wurzburg in Germany and completed his postdoctoral training at the Korea Research Institute of Bioscience and Biotechnology and, until most recently, at the NIH CCR.

Li Yang, Ph.D.
Yang joins CCR’s Laboratory of Cancer Biology and Genetics. She received her Ph.D. and postdoctoral training in the Cancer Biology Department at Vanderbilt University. Her laboratory is devoted to mechanisms of inflammation underlying tumor initiation, invasion, and metastasis, with the emphasis on the contribution of TGF-beta signaling and COX-2 pathways.